Chemoinformaics analysis of PIMARA-8(14),15-DIEN-19-OIC-ACID
| Molecular Weight | 160.169 | nRot | 6 |
| Heavy Atom Molecular Weight | 148.073 | nRig | 2 |
| Exact Molecular Weight | 160.074 | nRing | 0 |
| Solubility: LogS | -0.356 | nHRing | 0 |
| Solubility: LogP | 0.532 | No. of Aliphatic Rings | 0 |
| Acid Count | 2 | No. of Aromatic Rings | 0 |
| Base Count | 0 | No. of Aliphatic Carbocycles Rings | 0 |
| Atoms Count | 23 | No. of Aliphatic Hetero Cycles | 0 |
| No. of Heavy Atom | 11 | No. of Aromatic Carbocycles | 0 |
| nHetero | 4 | No. of Aromatic Hetero Cycles | 0 |
| nBridge Head | 0 | No. Saturated Carbocycles | 0 |
| No. of Hydrogen atom | 12 | No. of Saturated Hetero Cycles | 0 |
| No. of Carbon atom | 7 | No. of Saturated Rings | 0 |
| No. of Nitrogen atom | 0 | No. of Arom Atom | 0 |
| No. of Oxygen atom | 4 | No. of Arom Bond | 0 |
| nHA | 2 | APOL | 22.8995 |
| nHD | 2 | BPOL | 13.7745 |
| QED | 0.57 |
| Synth | 1.607 |
| Natural Product Likeliness | 0.511 |
| NR-PPAR-gamma | 0.859 |
| Lipinski | Accepted |
| Pfizer | Accepted |
| GSK | Accepted |
| Golden Triangle | Rejected |
| Pgp-inh | 0 |
| Pgp-sub | 0.003 |
| HIA | 0.179 |
| CACO-2 | -5.834 |
| MDCK | 0.000291304 |
| BBB | 0.086 |
| PPB | 0.649065 |
| VDSS | 0.255 |
| FU | 0.385289 |
| CYP1A2-inh | 0.01 |
| CYP1A2-sub | 0.057 |
| CYP2c19-inh | 0.024 |
| CYP2c19-sub | 0.047 |
| CYP2c9-inh | 0.007 |
| CYP2c9-sub | 0.956 |
| CYP2d6-inh | 0.014 |
| CYP2d6-sub | 0.111 |
| CYP3a4-inh | 0.007 |
| CYP3a4-sub | 0.006 |
| CL | 3.079 |
| T12 | 0.863 |
| hERG | 0.005 |
| Ames | 0.011 |
| ROA | 0.007 |
| SkinSen | 0.121 |
| Carcinogencity | 0.093 |
| EI | 0.982 |
| Respiratory | 0.032 |
| NR-Aromatase | 0.007 |
| Antiviral | No |
| Prediction | 0.943853 |